The Role of DLNO in the Functional Assessment of Patients with Idiopathic Pulmonary Fibrosis

<i>Background and Objectives:</i> Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by alveolar-capillary membrane remodeling and impaired gas diffusion. The diffusing capacity of the lung for nitric oxide (DLNO) has been proposed as a physiological parameter reflecting membrane diffusing capacity and pulmonary vascular involvement, potentially providing complementary information to diffusing capacity of the lung for carbon monoxide (DLCO). This study aimed to evaluate the role of DLNO in the functional assessment of patients with IPF and its correlation with clinical and echocardiographic outcomes. <i>Materials and Methods:</i> This observational, retrospective study included 35 consecutive IPF patients receiving antifibrotic therapy between February and December 2023. All participants underwent plethysmography, combined single-breath DLNO and DLCO testing, six-minute walk test (6MWT), mMRC dyspnea scale assessment, and echocardiography for the estimation of a higher probability of pulmonary hypertension (PH). <i>Results:</i> DLNO was significantly lower in males compared to females (49.3 ± 16.7% vs. 74.6 ± 16.1%, <i>p</i> < 0.001), with a reduced DLNO/DLCO ratio in men. DLNO correlated with oxygen therapy requirement (<i>p</i> = 0.010) and lower oxygen saturation during the 6MWT (<i>p</i> = 0.021). Patients with higher echocardiographic probability of PH showed markedly reduced DLNO values (17.6 ± 7.6%, <i>p</i> = 0.016) and higher FVC/DLNO ratios (2.31 ± 0.85 vs. 1.65 ± 0.64, <i>p</i> = 0.023), together with lower DLCO levels (<i>p</i> = 0.037). <i>Conclusions:</i> DLNO may complement DLCO in the evaluation of gas exchange and alveolar-capillary dysfunction in IPF. Although preliminary, these findings support the potential clinical utility of DLNO as an adjunct parameter in the functional characterization of IPF. Further multicenter studies are warranted to confirm these results.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-01-19
DOI
https://doi.org/10.3390/medicina62010208
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of DLNO in the Functional Assessment of Patients with Idiopathic Pulmonary Fibrosis

G Scioscia, Paola Paola Rogliani, Josuel Ora, Pasquale Tondo et al.
Medicina
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

The Role of DLNO in the Functional Assessment of Patients with Idiopathic Pulmonary Fibrosis

G Scioscia, Paola Paola Rogliani, Josuel Ora, Pasquale Tondo, Bartolomeo Zerillo, Matteo Pio Natale, Donato Lacedonia, Matteo Salvatore Di Maggio
article en

Abstract

<i>Background and Objectives:</i> Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by alveolar-capillary membrane remodeling and impaired gas diffusion. The diffusing capacity of the lung for nitric oxide (DLNO) has been proposed as a physiological parameter reflecting membrane diffusing capacity and pulmonary vascular involvement, potentially providing complementary information to diffusing capacity of the lung for carbon monoxide (DLCO). This study aimed to evaluate the role of DLNO in the functional assessment of patients with IPF and its correlation with clinical and echocardiographic outcomes. <i>Materials and Methods:</i> This observational, retrospective study included 35 consecutive IPF patients receiving antifibrotic therapy between February and December 2023. All participants underwent plethysmography, combined single-breath DLNO and DLCO testing, six-minute walk test (6MWT), mMRC dyspnea scale assessment, and echocardiography for the estimation of a higher probability of pulmonary hypertension (PH). <i>Results:</i> DLNO was significantly lower in males compared to females (49.3 ± 16.7% vs. 74.6 ± 16.1%, <i>p</i> < 0.001), with a reduced DLNO/DLCO ratio in men. DLNO correlated with oxygen therapy requirement (<i>p</i> = 0.010) and lower oxygen saturation during the 6MWT (<i>p</i> = 0.021). Patients with higher echocardiographic probability of PH showed markedly reduced DLNO values (17.6 ± 7.6%, <i>p</i> = 0.016) and higher FVC/DLNO ratios (2.31 ± 0.85 vs. 1.65 ± 0.64, <i>p</i> = 0.023), together with lower DLCO levels (<i>p</i> = 0.037). <i>Conclusions:</i> DLNO may complement DLCO in the evaluation of gas exchange and alveolar-capillary dysfunction in IPF. Although preliminary, these findings support the potential clinical utility of DLNO as an adjunct parameter in the functional characterization of IPF. Further multicenter studies are warranted to confirm these results.

MedicinaVol. 62(1)
University of Foggia (IT), University of Rome Tor Vergata (IT)
Openalex Percentile: Top 85%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.